Skip to content
Screener

Opko Health OPK Total Revenue

Total Revenue at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$3.04B+10.2%
Regenxbio logo
RegenxbioRGNX
$108.02M+406%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$58.82M+10.3%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$214M+28.1%
PTH
Pelthos TherapeuticsPTHS
$10.91M
Exelixis logo
ExelixisEXEL
$628.69M+10.6%

Segments

By geography

See full
US$88.81M
IE$41.66M
CL$16.43M
ES$8.45M
MX$7.04M
IL$0

By product

See full
Intellectual Property And Other$46.1M
Transfer Of Intellectual Property And Other$46.09M+208%
Rayaldee$14.26M

Other financials

Income statement

See full
Gross profit$80.0M+62.0%
Operating income-$7.0M+88.4%
Net income-$8.4M+94.3%
EPS (diluted)-$0.01+94.7%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$49.9M-7.5%
Total equity$1.2B-8.7%
Total assets$1.8B-7.3%

Cash flow

See full
Operating cash flow-$43.5M+47.9%
CapEx$3.0M-8.5%
Free cash flow-$46.5M+46.4%

Valuation

See full
Market cap$985.15M-2.3%
P/S1.7×+0.2×

Profitability

See full
Gross margin40.8%+8.1pp
Operating margin-8.2%-3.5pp
Net margin-12.4%-4.3pp
FCF margin-22.8%-6.7pp

Returns & leverage

See full
Return on equity-5.9%-2.1pp
Debt / equity0.0×
Current ratio3.3×-0.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Opko Health’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-318090
Line itemFor the three months ended June 30, 2026For the three months ended June 30, 2025For the six months ended June 30, 2026For the six months ended June 30, 2025
Revenue from services$74,549$101,101$146,735$203,945
Revenue from products42,94140,74380,98475,585
Revenue from transfer of intellectual property and other46,09014,96360,05827,229
Total revenues163,580156,807287,777306,759
Costs and expenses:
Cost of service revenue58,46282,383114,604166,901
Cost of product revenue25,10125,02247,39947,836
Selling, general and administrative52,92459,597101,531118,683

Item 1. Financial Statements

FAQ

What is Opko Health's total revenue?
Opko Health (OPK) reported total revenue of $163.58M in Q2 2026.
How has Opko Health's total revenue changed year-over-year?
Opko Health's total revenue increased by 4.3% year-over-year, from $156.81M to $163.58M.
What is the long-term trend for Opko Health's total revenue?
Over 4 years (2021 to 2025), Opko Health's total revenue has grown at a -23.5% compound annual growth rate (CAGR), from $1.77B to $606.88M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Opko Health's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude